Clomiphene for Men: Evidence on Testosterone, Fertility and Side Effects

Clomiphene raises a man’s own testosterone instead of replacing it. A 2022 meta-analysis of 19 studies with 1,642 men with low testosterone found that testosterone, free testosterone, LH, FSH, SHBG and estradiol all rose during treatment, and symptom scores improved (Huijben 2022). It is approved only for women (ovulation problems), so use in men is off-label.

This page covers how clomiphene works, its approval history, what the trials in men found, fertility, side effects, and how it compares with testosterone therapy (TRT), enclomiphene and anastrozole. For its use after a cycle, see Clomid PCT.

Clomiphene at a glance

What clomiphene for men actually does

Testosterone is controlled by a chain: the hypothalamus signals the pituitary, which releases LH and FSH, which tell the testes to make testosterone and sperm. Estrogen applies a brake to this chain. Clomiphene blocks estrogen receptors in the brain, so the brake comes off and LH and FSH rise. In 12 healthy men, 50 mg/day for 30 days raised testosterone by 146%, LH by 177% and FSH by 170% (Miller 2019).

Clomiphene is two molecules in one. The label says 30–50% is zuclomiphene, the cis-isomer (label). Zuclomiphene clears slowly and builds up: in men on long-term treatment its blood level was about 20 times that of enclomiphene (Helo 2017). Enclomiphene is now studied on its own: see enclomiphene for men.

Approval and regulatory status

• US: Clomid (NDA 016131) was approved on 1 February 1967 for ovulation problems in women who want to become pregnant (Drugs@FDA). It is prescription-only; use in men is off-label (label).
• Guidelines: According to a 2026 British Society for Sexual Medicine statement, the American Urological Association lists clomiphene as an alternative to testosterone for men who want to keep their fertility (BSSM 2026).
• Germany: listed in the Anti-Doping Act annex; possessing a “non-small quantity” for doping in sport is an offense (AntiDopG).
• Sport: prohibited at all times under WADA S4.2. Since 2026, labs report it in urine only above 2.0 ng/mL because eggs or poultry from treated hens can leave traces (WADA TL26).

What the studies in men found

Testosterone, symptoms and body composition

Testosterone. The rise is consistent across studies (Huijben 2022). Compared with testosterone therapy, a 2026 meta-analysis of 11 studies (1,512 men) found no significant difference in testosterone vs testosterone gel, higher levels with injected testosterone, and lower libido scores on clomiphene (Constantinou 2026).

Symptoms. Symptom scores (the ADAM questionnaire) improved in the pooled studies (Huijben 2022). In the long-term study, 77% of men treated for more than 3 years reported better symptoms (Krzastek 2019). Most of this is observational.

Body composition. In the 12-week placebo-controlled trial in obese men, lean mass and muscle mass improved (Soares 2018).

How long until results? Testosterone more than doubled within 30 days in healthy men (Miller 2019), and the placebo-controlled trial measured its effects at 12 weeks (Soares 2018). Sperm production takes longer to change than hormones.

Fertility and sperm

This is the main reason men use clomiphene instead of testosterone. Testosterone therapy can reduce sperm counts to very low levels or zero within 12–24 weeks, according to the BSSM statement (BSSM 2026). Clomiphene did not harm sperm production in the studies: semen did not change significantly vs anastrozole in a randomized trial (Helo 2015), and semen volume and concentration did not change in a retrospective study, where only enclomiphene raised the total motile sperm count (Thomas 2023).

Side effects and safety

Clomiphene vs TRT, enclomiphene and anastrozole

More detail: enclomiphene, anastrozole, SARMs vs TRT.

Clomiphene after steroids or SARMs (PCT)

Clomiphene is the drug most used off-label for recovery after anabolic steroids (Bandura 2026). The data are observational: in 79 men after short steroid use, clomiphene with or without hCG sped up hormone recovery, though untreated men also normalized by month 6 (İbis 2026). Nothing has been published on clomiphene after SARMs. Details: Clomid PCT and SARMs PCT, or try the PCT & Bloodwork Planner.

Bloodwork measured in the studies

The studies above tracked total testosterone, LH, FSH, estradiol, SHBG, HDL and the lipid panel, hematocrit and PSA; the label adds liver function. These are the markers the research used, not a monitoring plan. What each one means: SARMs bloodwork.

Half-life and detection

The two isomers clear at very different speeds. The label says zuclomiphene stayed detectable for more than a month after single doses (label), and a study in women could not even calculate a terminal half-life because the tail was so flat (Ghobadi 2009). In an anti-doping study of 12 men, zuclomiphene was still found in urine 121 to more than 261 days after a 30-day course (Miller 2019).

Where to buy clomiphene

Clomiphene is a prescription medicine in the US. Sarmguide’s current pick for research-grade clomiphene is SwissChems Clomiphene 25 mg capsules, sold for laboratory research use, with third-party lab results per batch. See Buy PCT.

Bottom line

Clomiphene reliably raises testosterone, LH and FSH in men whose hormone axis works, while keeping sperm production. The evidence is mostly small trials and observational studies, and regulators approved it only for women. Its costs are visual symptoms, mood changes, higher estradiol, lower HDL and a zuclomiphene tail that lasts for months.